2022
Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations
Denoble A, Goldstein S, Wein L, Grotegut C, Federspiel J. Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations. JACC Advances 2022, 1: 100157. PMID: 36684662, PMCID: PMC9851052, DOI: 10.1016/j.jacadv.2022.100157.Peer-Reviewed Original ResearchSevere maternal morbidityIschemic heart diseaseDelivery hospitalizationsComplex survey methodsCardiac diseaseCardiac diagnosisMaternal morbidityHeart diseasePre-existing ischaemic heart diseasePre-existing ischemic heart diseaseNontransfusion severe maternal morbidityWorld Health Organization classificationClass IAdverse pregnancy outcomesNationwide Readmissions DatabaseRelative risk regressionWorld Health Organization class IPregnancy outcomesPrimary outcomeRetrospective studyAdverse outcomesUnadjusted analysesOrganization classificationRisk regressionWorse outcomes
2014
Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical Conditions
DeNoble AE, Hall KS, Xu X, Zochowski MK, Piehl K, Dalton VK. Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical Conditions. Obstetrics And Gynecology 2014, 123: 1213-1220. PMID: 24807345, PMCID: PMC4169713, DOI: 10.1097/aog.0000000000000279.Peer-Reviewed Original ResearchConceptsChronic medical conditionsPrescription contraceptionChronic conditionsMedical conditionsCommunity-level socioeconomic statusAdministrative claims recordsTotal outpatient visitsInflammatory bowel diseaseSystemic lupus erythematosusCervical cancer screeningMultivariable logistic regressionChronic condition statusBowel diseaseLupus erythematosusOrder of prevalencePharmacy claimsPrimary outcomeOutpatient visitsRheumatoid arthritisAdverse outcomesCancer screeningUnplanned pregnancyObservational studyStudy populationInsured women